Double dose Kaletra in childre
Not Applicable
- Conditions
- HIV/AIDSTuberculosis
- Registration Number
- PACTR2008060000852767
- Lead Sponsor
- niversity of Cape Town
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
HIV-infected children with and without TB (controls) aged 6 months to 15 years.
Children eligible for, or, established on protease inhibitor-
based HAART according to National Treatment Guidelines
Exclusion Criteria
ALT > 10X the upper limit of normal (grade 3 or 4).
Known renal, hepatic or chronic GIT disease.
Receiving drugs other than the study medication known to potently induce or inhibit CYP3A4 or alter the PK of LPV.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method